Carolien Koks

722 total citations
9 papers, 607 citations indexed

About

Carolien Koks is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Carolien Koks has authored 9 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Carolien Koks's work include Immunotherapy and Immune Responses (4 papers), Immune cells in cancer (3 papers) and RNA Interference and Gene Delivery (3 papers). Carolien Koks is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune cells in cancer (3 papers) and RNA Interference and Gene Delivery (3 papers). Carolien Koks collaborates with scholars based in Belgium, Germany and United States. Carolien Koks's co-authors include Stefaan Van Gool, Abhishek D. Garg, Lien Vandenberk, Patrizia Agostinis, Louis Boon, Tina Verschuere, Norbert Graf, Steven De Vleeschouwer, Michael Ehrhardt and Mattéo Riva and has published in prestigious journals such as Cell Death and Differentiation, Science Translational Medicine and International Journal of Cancer.

In The Last Decade

Carolien Koks

9 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolien Koks Belgium 7 360 268 148 127 109 9 607
Lien Vandenberk Belgium 6 425 1.2× 315 1.2× 170 1.1× 117 0.9× 125 1.1× 7 682
Catalina Martínez Colombia 8 285 0.8× 397 1.5× 146 1.0× 83 0.7× 100 0.9× 17 692
Cornell Allen United States 13 257 0.7× 274 1.0× 378 2.6× 218 1.7× 66 0.6× 22 693
Alireza Labani‐Motlagh Sweden 6 363 1.0× 352 1.3× 282 1.9× 78 0.6× 94 0.9× 7 709
Xiang Ao China 12 159 0.4× 196 0.7× 237 1.6× 75 0.6× 57 0.5× 17 533
Zhenqing Feng China 14 204 0.6× 368 1.4× 261 1.8× 84 0.7× 72 0.7× 26 674
Qun Tao China 12 293 0.8× 209 0.8× 210 1.4× 112 0.9× 31 0.3× 26 549
K. Kosmatopoulos France 7 292 0.8× 146 0.5× 215 1.5× 33 0.3× 90 0.8× 17 551
Anthony K. Park United States 11 255 0.7× 724 2.7× 214 1.4× 367 2.9× 210 1.9× 23 835
Tamara Laskowski United States 7 403 1.1× 395 1.5× 201 1.4× 76 0.6× 90 0.8× 8 645

Countries citing papers authored by Carolien Koks

Since Specialization
Citations

This map shows the geographic impact of Carolien Koks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolien Koks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolien Koks more than expected).

Fields of papers citing papers by Carolien Koks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolien Koks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolien Koks. The network helps show where Carolien Koks may publish in the future.

Co-authorship network of co-authors of Carolien Koks

This figure shows the co-authorship network connecting the top 25 collaborators of Carolien Koks. A scholar is included among the top collaborators of Carolien Koks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolien Koks. Carolien Koks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Eich, Marcus, et al.. (2020). Impaired DNA repair in mouse monocytes compared to macrophages and precursors. DNA repair. 98. 103037–103037. 9 indexed citations
2.
Garg, Abhishek D., Lien Vandenberk, Shentong Fang, et al.. (2017). Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing. Cell Death and Differentiation. 24(5). 832–843. 91 indexed citations
3.
Garg, Abhishek D., Lien Vandenberk, Carolien Koks, et al.. (2016). Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma. Science Translational Medicine. 8(328). 328ra27–328ra27. 223 indexed citations
4.
Vandenberk, Lien, Abhishek D. Garg, Tina Verschuere, et al.. (2015). Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. OncoImmunology. 5(2). e1083669–e1083669. 50 indexed citations
5.
Koks, Carolien, Steven De Vleeschouwer, Norbert Graf, & Stefaan W. Van Gool. (2015). Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?. Journal of Cancer. 6(3). 203–217. 28 indexed citations
6.
Vandenberk, Lien, Abhishek D. Garg, Patrizia Agostinis, et al.. (2014). Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade glioma. Journal for ImmunoTherapy of Cancer. 2(S3). 1 indexed citations
7.
Koks, Carolien, Abhishek D. Garg, Michael Ehrhardt, et al.. (2014). Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death. International Journal of Cancer. 136(5). E313–25. 175 indexed citations
8.
Luyckx, Ariane, Elio Schouppe, Omer Rutgeerts, et al.. (2011). Subset characterization of myeloid-derived suppressor cells arising during induction of BM chimerism in mice. Bone Marrow Transplantation. 47(7). 985–992. 29 indexed citations
9.
Koks, Carolien, et al.. (2011). Immunotherapy for malignant glioma: current results of the clinical trials. Klinische Pädiatrie. 223(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026